Shire faces battle against ADHD generics

Shire, the maker of ADHD drugs Adderall XR and Vyvanse, had an excellent Q1 but now faces a challenge: Its two top products are threatened by a generic that Teva brought to market on April 2, BNet Pharma reports. Report